- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 56.39M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 54.97M sh |
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 54.86M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $2.13M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.65M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $4.03M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $6.95M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $146M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $151.17M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $335.46M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $337.89M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $464.81M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $466.3M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $893.15M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $894.03M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.07 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $32.49M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $33.46M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.8M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.32M |
| Net Income | Q1 2026 · Mar 31, 2026 | $4.23M |
| Net Income | Q1 2026 · Mar 31, 2025 | $2.33M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $9.95M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $16.73M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $45.81M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $53.18M |
| Revenue | Q1 2026 · Mar 31, 2026 | $81.38M |
| Revenue | Q1 2026 · Mar 31, 2025 | $86.67M |